Slow omeprazole metabolizers are also poor S-mephenytoin hydroxylators.
about
CYP2C19 polymorphism influences Helicobacter pylori eradicationIdentification of human liver cytochrome P450 isoforms mediating omeprazole metabolismThe role of S-mephenytoin 4'-hydroxylase in imipramine metabolism by human liver microsomes: a two-enzyme kinetic analysis of N-demethylation and 2-hydroxylationIdentification of human liver cytochrome P450 isoforms mediating secondary omeprazole metabolism.Diazepam metabolism by human liver microsomes is mediated by both S-mephenytoin hydroxylase and CYP3A isoforms.In vitro proguanil activation to cycloguanil by human liver microsomes is mediated by CYP3A isoforms as well as by S-mephenytoin hydroxylase.Interphenotype differences in disposition and effect on gastrin levels of omeprazole--suitability of omeprazole as a probe for CYP2C19A study of the interaction of omeprazole and warfarin in anticoagulated patientsA study of the interaction between omeprazole and cyclosporine in renal transplant patients.The N-demethylation of imipramine correlates with the oxidation of S-mephenytoin (S/R-ratio). A population study.Effects of CYP2C19 loss-of-function variants on the eradication of H. pylori infection in patients treated with proton pump inhibitor-based triple therapy regimens: a meta-analysis of randomized clinical trials.Inducibility of CYP1A2 by omeprazole in vivo related to the genetic polymorphism of CYP1A2.The effect of ethinyloestradiol and levonorgestrel on the CYP2C19-mediated metabolism of omeprazole in healthy female subjectsFormation of omeprazole sulphone but not 5-hydroxyomeprazole is inhibited by grapefruit juice.Effect of omeprazole on concentrations of clarithromycin in plasma and gastric tissue at steady state.The Influence of CYP2C19 Polymorphism on Eradication of Helicobacter pylori: A Prospective Randomized Study of Lansoprazole and Rabeprazole.Interaction of proton pump inhibitors with cytochromes P450: consequences for drug interactions.Inhibitors of imipramine metabolism by human liver microsomes.Pharmacodynamic and kinetic effect of rabeprazole on serum gastrin level in relation to CYP2C19 polymorphism in Chinese HansPharmacokinetics and effect on caffeine metabolism of the proton pump inhibitors, omeprazole, lansoprazole, and pantoprazole.Absence of an inhibitory effect of omeprazole and nizatidine on phenytoin disposition, a marker of CYP2C activity.P450 Pharmacogenetics in Indigenous North American Populations.
P2860
Q27005916-FD7C1A4C-52DA-47E9-A8F4-8918818F7499Q34345774-70D58677-E420-4C1D-A819-136D2D7692B3Q34346107-8D67C47A-7BFA-450B-865D-C49EBF82B918Q34346434-D399FEA9-C897-48D2-9383-985BCEA4FBD1Q34346567-E2AA9C04-4F25-4F2F-B591-6D289C84BD4EQ34346652-C3BA5691-929A-417A-B315-2161EDADAA49Q34347232-7AC1A2E4-1593-4098-93D4-5528C0671861Q34403343-B1FF3AAF-B4AE-4ED1-AF1A-E8F8E9E58F11Q34403554-E19E9BE7-7775-4731-ACAC-7FF4ECF24D5FQ34403769-D2B7CE18-A9FA-44F1-88E8-47C9184D0AC7Q34706721-6F857B8F-DC78-4363-A630-3C201CCA1EF9Q35804108-071730F4-225B-4A65-BC63-7E080095D461Q35825470-2FA15D02-49C0-45DD-A6E2-7963B33375E6Q36055042-14233032-01CE-4873-A0D2-68FC5244D0E0Q39780438-44198E97-A364-4F21-87E3-E40B47ECE961Q41120052-DC894927-5846-4214-BA98-80849F43498DQ41482802-DA606C3F-F8EC-4D9E-8491-3617839BC32DQ41769510-3BDBF4AA-F454-45D8-8210-008B8DDEC5CCQ41834927-E2175466-3F48-409C-81CC-E603014A0895Q42116041-CC54EFC4-0B2D-4F01-A0AF-DE4A91E3B6A1Q42140757-381853F6-10AB-4E59-BF26-F675350C6BF6Q47546933-72C13784-6048-4A93-B4BF-D86AA15F1DCC
P2860
Slow omeprazole metabolizers are also poor S-mephenytoin hydroxylators.
description
1990 nî lūn-bûn
@nan
1990年の論文
@ja
1990年学术文章
@wuu
1990年学术文章
@zh-cn
1990年学术文章
@zh-hans
1990年学术文章
@zh-my
1990年学术文章
@zh-sg
1990年學術文章
@yue
1990年學術文章
@zh
1990年學術文章
@zh-hant
name
Slow omeprazole metabolizers are also poor S-mephenytoin hydroxylators.
@en
Slow omeprazole metabolizers are also poor S-mephenytoin hydroxylators.
@nl
type
label
Slow omeprazole metabolizers are also poor S-mephenytoin hydroxylators.
@en
Slow omeprazole metabolizers are also poor S-mephenytoin hydroxylators.
@nl
prefLabel
Slow omeprazole metabolizers are also poor S-mephenytoin hydroxylators.
@en
Slow omeprazole metabolizers are also poor S-mephenytoin hydroxylators.
@nl
P2093
P1476
Slow omeprazole metabolizers are also poor S-mephenytoin hydroxylators
@en
P2093
C G Regårdh
L Bertilsson
M L Dahl-Puustinen
T Andersson
P304
P356
10.1097/00007691-199007000-00020
P577
1990-07-01T00:00:00Z